Health Care & Life Sciences » Pharmaceuticals | Botanix Pharmaceuticals Ltd.

Botanix Pharmaceuticals Ltd.

Botanix Pharmaceuticals Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0.02
Market Cap
AUD170.29 M
Shares Outstanding
774.03 M
Public Float
526.11 M

Profile

Address
50 Angove Street
North Perth Western Australia (WA) 6006
Australia
Employees -
Website http://www.botanixpharma.com
Updated 07/08/2019
Botanix Pharmaceuticals Ltd. engages in the development of next generation therapeutics for the treatment of skin diseases. It focuses on the treatment of patients battling with acne, psoriasis, and atoptic dermatitis. The company also develops pharmaceutical ingredient known as cannabidol, which seeks to treat epilepsy, pain, arthritis, and schizophrenia.

Financials

View All
Created with Highcharts 5.0.14Botanix Pharmaceuticals Ltd.Net Income. Fiscal year is July-June. All values AUD Thousands.1 1311 1315275271 7081 7084 7624 76211 01111 0112014201520162017201802.5k5k7.5k10k12.5k

H. Bill Bosch
Executive Director & Chief Scientific Officer
Matthew Callahan
Executive Director